Literature DB >> 7681159

Characterization of the protein encoded by the flt3 (flk2) receptor-like tyrosine kinase gene.

S D Lyman1, L James, J Zappone, P R Sleath, M P Beckmann, T Bird.   

Abstract

We have developed rabbit polyclonal antibodies to the C-terminus of the flt3-encoded protein, which is a member of the receptor tyrosine kinase family. Immunoprecipitation using this antiserum brings down two protein bands, a major band of 143 kDa and a less abundant, more diffuse, band of 158 kDa. Pulse-chase analysis of flt3 protein from transfected COS-7 cells shows that the larger band is derived from the smaller one and presumably represents maturation of the protein from a glycosylated high-mannose form to a complex carbohydrate form. N-glycosidase F digestion confirmed the presence of N-linked carbohydrates, and cell-surface labeling of flt3-transfected cells indicated that the 158-kDa glycoprotein is the species found on the cell surface. A mutated form of the flt3 protein that was defective in its glycosylational processing was identified. Western blotting of the immunoprecipitated flt3 protein showed that it is heavily phosphorylated on tyrosine, and that this phosphorylation probably occurs in the absence of ligand. In this regard, the flt3 protein resembles the c-erbB2 protein, which is also highly phosphorylated in the absence of ligand. These data suggest that the flt3 receptor regulates the growth and differentiation of cells via an as yet unknown ligand.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681159

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  21 in total

1.  Flt3 ligand expands CD103⁺ dendritic cells and FoxP3⁺ T regulatory cells, and attenuates Crohn's-like murine ileitis.

Authors:  Colm B Collins; Carol M Aherne; Eóin N McNamee; Matthew D P Lebsack; Holger Eltzschig; Paul Jedlicka; Jesús Rivera-Nieves
Journal:  Gut       Date:  2011-11-07       Impact factor: 23.059

Review 2.  Biology, clinical relevance, and molecularly targeted therapy in acute leukemia with FLT3 mutation.

Authors:  Hitoshi Kiyoi; Tomoki Naoe
Journal:  Int J Hematol       Date:  2006-05       Impact factor: 2.490

Review 3.  Clinical significance of FLT3 in leukemia.

Authors:  Hitoshi Kiyoi; Masamitsu Yanada; Kazutaka Ozekia
Journal:  Int J Hematol       Date:  2005-08       Impact factor: 2.490

4.  Fms-like tyrosine kinase 3 receptor ligand (Flt3L)-based vaccination administered with an adenoviral vector prevents tumor growth of colorectal cancer in a BALB/c mouse model.

Authors:  Carina Riediger; Gerhard Wingender; Percy Knolle; Sebastian Aulmann; Wolfgang Stremmel; Jens Encke
Journal:  J Cancer Res Clin Oncol       Date:  2013-10-10       Impact factor: 4.553

Review 5.  Signal transduction of oncogenic Flt3.

Authors:  Chunaram Choudhary; Carsten Müller-Tidow; Wolfgang E Berdel; Hubert Serve
Journal:  Int J Hematol       Date:  2005-08       Impact factor: 2.490

6.  Association between increased mutation rates in DNMT3A and FLT3-ITD and poor prognosis of patients with acute myeloid leukemia.

Authors:  Qiurong Zhang; Xiao Wu; Jing Cao; Feng Gao; Kun Huang
Journal:  Exp Ther Med       Date:  2019-08-14       Impact factor: 2.447

7.  Tyrosine phosphorylation regulates maturation of receptor tyrosine kinases.

Authors:  Dirk-E Schmidt-Arras; Annette Böhmer; Boyka Markova; Chunaram Choudhary; Hubert Serve; Frank-D Böhmer
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

8.  Efficient production of bioactive recombinant human Flt3 ligand in E. coli.

Authors:  Kenneth Verstraete; Sina Koch; Sevgi Ertugrul; Isabel Vandenberghe; Maarten Aerts; Gonzalez Vandriessche; Christian Thiede; Savvas N Savvides
Journal:  Protein J       Date:  2009-02       Impact factor: 2.371

9.  Attenuation of vaccinia virus by the expression of human Flt3 ligand.

Authors:  Kamila Zurkova; Petr Hainz; Jitka Krystofova; Luda Kutinova; Miloslav Sanda; Sarka Nemeckova
Journal:  Virol J       Date:  2010-05-26       Impact factor: 4.099

10.  Mitogenic signalling and substrate specificity of the Flk2/Flt3 receptor tyrosine kinase in fibroblasts and interleukin 3-dependent hematopoietic cells.

Authors:  M Dosil; S Wang; I R Lemischka
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.